LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

Why I’d buy AstraZeneca plc and Taylor Wimpey plc today

Harvey Jones reckons AstraZeneca plc (LON: AZN) and Taylor Wimpey plc (LON: TW) are two of the most tempting plays…

Read more »

Investing Articles

Should you invest in AstraZeneca plc right now?

Could AstraZeneca plc (LON: AZN) help you invest your way to a fortune?

Read more »

Investing Articles

AstraZeneca plc isn’t the only way to play the world’s ageing population

AstraZeneca plc (LON: AZN) may have long-term potential, but could this 'niche' healthcare stock be a better way to play…

Read more »

Investing Articles

Why AstraZeneca plc shares could be the buy of the decade

AstraZeneca plc's (LON:AZN) share price could double in five years, says G A Chester.

Read more »

Investing Articles

AstraZeneca plc isn’t the only high-growth stock I’d buy today

This stock could deliver high returns alongside AstraZeneca plc (LON: AZN).

Read more »

Investing Articles

Why I’d buy Neil Woodford’s favourite dividend stock AstraZeneca plc in 2018

2018 could be the year that AstraZeneca plc's (LON: AZN) turnaround finally starts to take hold.

Read more »

Investing Articles

A Neil Woodford recovery stock I’d buy alongside AstraZeneca plc

Bolstering the risk of smaller-cap stocks by combining them with giants like AstraZeneca plc (LON: AZN) could be a winning…

Read more »

Investing Articles

AstraZeneca plc isn’t the only pharma stock I’d buy today

Royston Wild explains why AstraZeneca plc (LON: AZN) could make you a fortune.

Read more »

Investing Articles

Why I’d buy FTSE 100 star Legal & General Group plc as profits set to hit record high

Roland Head explains why Legal & General Group plc (LON:LGEN) is one of his top FTSE 100 (INDEXFTSE:UKX) picks.

Read more »

Investing Articles

Why I’d sell this FTSE 250 flop and buy AstraZeneca plc instead

G A Chester sees a much stronger investment case for AstraZeneca plc (LON:AZN) than this FTSE 250 (INDEXFTSE:MCX) stock.

Read more »

Investing Articles

Is AstraZeneca plc a strong buy after Q3 results?

Is AstraZeneca plc (LON: AZN) still on course for a recovery?

Read more »

Investing Articles

Why I’d buy AstraZeneca plc over this soaring growth stock

Harvey Jones says AstraZeneca plc (LON: AZN) could hit new peaks and put this biotechnology upstart in its place.

Read more »